Acta Obstetricia Et Gynecologica Scandinavica · 1979 · 19 citations · 11 references
MedicineEndocrinologyGynecologyInfertilityReproductive EndocrinologyReproductive MedicineFemale InfertilityHormonal EvaluationLuteal FunctionMenstrual CycleOvulatory DisordersReproductive Endocrinology PharmacotherapyBromocriptine TreatmentLuteal InsufficiencyLuteal Phase PhysiologyLuteal Phase RegulationPhysiological Hyperprolactinemia
Twelve patients with infertility and insufficent luteal function were studied during a control cycle, and during a cycle when 2.5 mg of bromocriptine was given twice daily. Serum levels of prolactin, progesterone, estradiol-17-beta, FSH and LH were determined during both cycles. Endometrial biopsies were taken from most patients during the late luteal phase. Two patients had persistent hyperprolactinemia, approximately 35-45 ng/ml, and both had repeated insufficient luteal function, which completely reverted to normal during treatment. Five of the 10 normoprolactinemic patients achieved a normal luteal function during bromocriptine therapy. No pregnancies were achieved during the study but one patient later conceived during bromocriptine therapy.
11
Hyperprolactinemic Anovulatory Syndrome*
H. G. Bohnet, H.G. Dahlén, W. Wuttke et al. · The Journal of Clinical Endocrinology & Metabolism · 1976 · 264 citations
Medicine, Endocrinology, Gynecology +17